Ameritas Investment Partners, Inc. Reata Pharmaceuticals Inc Transaction History

Ameritas Investment Partners, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $16,398 - $21,811	207 Added 9.61%	2,360 $240,000
Q2 2021 Aug 06, 2021	BUY	$78.27 - $151.29 $168,515 - $325,727	2,153 New	2,153 $305,000
Q2 2020 Aug 05, 2020	SELL	$126.3 - $176.56 $250,958 - $350,824	-1,987 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$124.16 - $247.74 $12,540 - $25,021	101 Added 5.36%	1,987 $287,000
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $12,975 - $37,918	174 Added 10.16%	1,886 $386,000
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $14,689 - $17,832	189 Added 12.41%	1,712 $162,000
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $7,591 - $19,608	213 Added 16.26%	1,523 $125,000
Q2 2018 Aug 13, 2018	BUY	$19.94 - $40.96 $11,226 - $23,060	563 Added 75.37%	1,310 $46,000
Q2 2017 Aug 15, 2017	BUY	N/A	747	747 $24,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.